Overview

Conception.bio focuses on improving fertility treatments through advanced biotechnology. The company has developed a method to create viable egg cells from blood samples by transforming induced pluripotent stem cells (iPSCs) into mature egg cells. This process allows women to extend their fertility, provides options for couples facing infertility, and enables genetic screening of embryos to avoid hereditary diseases. Unlike many competitors, Conception.bio directly serves individuals and couples, including same-sex male couples, with a unique approach to egg cell development. The goal is to advance fertility science and offer new solutions to those struggling with reproductive challenges.

Simplify's Take

What believers are saying

• Growing demand for genetic screening boosts Conception's market potential.
• Fertility treatment market projected to grow at 8.5% CAGR until 2030.
• Advancements in gene-editing enhance Conception's genetic disease prevention offerings.

What critics are saying

• Ethical concerns about genetic editing may lead to regulatory challenges.
• Competing technologies like artificial gametes could surpass Conception's offerings.
• High development costs may limit accessibility for target consumers.

What makes Conception unique

• Conception turns skin cells into viable human eggs, a groundbreaking fertility innovation.
• The company enables genetic screening of embryos to prevent hereditary diseases.
• Conception's technology offers fertility solutions for same-sex male couples.

Help us improve and share your feedback! Did you find this helpful?

YesNo